TY - CHAP A1 - Bader, Martin A1 - Gassmann, Oliver ED - Thouvenin, Florent ED - Wildhaber, Isabelle T1 - Management von Technologietransfer T2 - Technologietransfer: Möglichkeiten und Grenzen rechtlicher Gestaltung, Referate der Tagung vom 30. November 2011 in St.Gallen Y1 - 2012 SN - 978-3-906049-02-1 SP - 9 EP - 29 PB - Institut für Rechtswissenschaft und Rechtspraxis CY - St. Gallen ER - TY - JOUR A1 - Schuhmacher, Alexander A1 - Gassmann, Oliver A1 - Hinder, Markus A1 - Kuss, Michael T1 - The present and future of project management in pharmaceutical R&D JF - Drug Discovery Today UR - https://doi.org/10.1016/j.drudis.2020.07.020 Y1 - 2021 UR - https://doi.org/10.1016/j.drudis.2020.07.020 SN - 1878-5832 VL - 26 IS - 1 SP - 1 EP - 4 PB - Elsevier CY - Amsterdam ER - TY - JOUR A1 - Schuhmacher, Alexander A1 - Hinder, Markus A1 - Boger, Nikolaj A1 - Gassmann, Oliver A1 - Hartl, Dominik T1 - Is the blockbuster imperative broken? JF - Drug Discovery Today UR - https://doi.org/10.1016/j.drudis.2023.103789 Y1 - 2023 UR - https://doi.org/10.1016/j.drudis.2023.103789 SN - 1878-5832 VL - 28 IS - 11 PB - Elsevier CY - Amsterdam ER - TY - JOUR A1 - Schuhmacher, Alexander A1 - Gassmann, Oliver A1 - Kuss, Michael A1 - Hinder, Markus T1 - The Art of Virtualizing Pharma R&D JF - Drug Discovery Today UR - https://doi.org/10.1016/j.drudis.2019.07.004 Y1 - 2019 UR - https://doi.org/10.1016/j.drudis.2019.07.004 SN - 1878-5832 VL - 24 IS - 11 SP - 2105 EP - 2107 PB - Elsevier CY - Amsterdam ER - TY - JOUR A1 - Schuhmacher, Alexander A1 - Hinder, Markus A1 - Dodel, Alexander A1 - Gassmann, Oliver A1 - Hartl, Dominik T1 - Investigating the origins of recent pharmaceutical innovation JF - Nature Reviews Drug Discovery UR - https://doi.org/10.1038/d41573-023-00102-z Y1 - 2023 UR - https://doi.org/10.1038/d41573-023-00102-z SN - 1474-1784 SN - 1474-1776 VL - 22 IS - 10 SP - 781 EP - 782 PB - Springer CY - London ER - TY - INPR A1 - Boemelburg, Raphael A1 - Schuhmacher, Alexander A1 - Gassmann, Oliver T1 - Open Innovation Strategies and Product Performance in Pharma R&D: Insights into Exploration and Exploitation T2 - SSRN UR - https://dx.doi.org/10.2139/ssrn.5562088 Y1 - 2025 UR - https://dx.doi.org/10.2139/ssrn.5562088 PB - Elsevier CY - Amsterdam ER -